Tocilizumab prescribing criteria for COVID-19 patients.
作者信息
Al-Qaaneh Ayman M, Al-Ghamdi Fuad H
机构信息
Clinical Pharmacy Services Division, Pharmacy Services Department, Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia.
Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
出版信息
Hum Vaccin Immunother. 2021 Apr 3;17(4):1128. doi: 10.1080/21645515.2020.1822137. Epub 2020 Oct 20.
Abstract
摘要
相似文献
1
Tocilizumab prescribing criteria for COVID-19 patients.
Hum Vaccin Immunother. 2021 Apr 3;17(4):1128. doi: 10.1080/21645515.2020.1822137. Epub 2020 Oct 20.
2
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
3
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.
Int J Mol Sci. 2021 Mar 17;22(6):3059. doi: 10.3390/ijms22063059.
4
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19.
Arch Med Res. 2020 Aug;51(6):595-597. doi: 10.1016/j.arcmed.2020.05.009. Epub 2020 May 21.
5
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation.
Ann Rheum Dis. 2021 Oct;80(10):1362-1363. doi: 10.1136/annrheumdis-2021-220040. Epub 2021 May 6.
6
The shortcomings of tocilizumab in COVID-19.
Infez Med. 2020 Dec 1;28(4):465-468.
7
A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients.
Transpl Infect Dis. 2021 Apr;23(2):e13556. doi: 10.1111/tid.13556. Epub 2021 Jan 22.
8
Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211019557. doi: 10.1177/23247096211019557.
9
Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
J Clin Immunol. 2021 May;41(4):738-747. doi: 10.1007/s10875-020-00949-6. Epub 2021 Jan 18.
10
COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.
J Med Virol. 2020 Nov;92(11):2260-2262. doi: 10.1002/jmv.26078. Epub 2020 Jun 19.
引用本文的文献
1
Preliminary assessment of cardiovascular effects and chemoinformatic analysis of total aqueous extract and fractions from Inula viscosa leaves.
J Mol Histol. 2025 Apr 17;56(3):134. doi: 10.1007/s10735-025-10408-4.
2
Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators.
J Clin Med. 2022 May 23;11(10):2945. doi: 10.3390/jcm11102945.
3
Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study.
Pharmaceutics. 2022 Mar 11;14(3):624. doi: 10.3390/pharmaceutics14030624.
本文引用的文献
1
The cytokine storm and COVID-19.
J Med Virol. 2021 Jan;93(1):250-256. doi: 10.1002/jmv.26232. Epub 2020 Sep 30.
2
[Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology].
Orv Hetil. 2020 Jun;161(26):1070-1077. doi: 10.1556/650.2020.31899.
3
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Inflamm Res. 2020 Sep;69(9):825-839. doi: 10.1007/s00011-020-01372-8. Epub 2020 Jun 11.
4
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.
Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.
5
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review.
J Clin Virol. 2020 Jun;127:104380. doi: 10.1016/j.jcv.2020.104380. Epub 2020 Apr 21.
6
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
7
Tocilizumab treatment in COVID-19: A single center experience.
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
Zotero 插件